News

Florence – September 21, 2026 -- The European Commission has granted marketing authorization for Ubeslo (obicetrapib 10 mg monotherapy) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg fixed-dose combination), marking the first global regulatory approval of obicetrapib for NewAmsterdam Pharma (Nasdaq: NAMS) and partner Menarini Group.

EU regulators authorize first CETP inhibitor for elevated LDL-C

The approval covers primary hypercholesterolaemia, including both heterozygous familial hypercholesterolaemia and non-familial or mixed dyslipidaemia. It follows a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use and stands as the first regulatory clearance of obicetrapib anywhere in the world.

Folsom, Calif. – September 21, 2026 -- Silverback Capital Inc. has launched a Second-Look Fix-and-Flip Pricing Program offering qualified California investors a 7.99% APR with a 12-month term through October 31, 2026.

Program targets investors comparing existing lender term sheets

The limited-time offer applies exclusively to business-purpose, non-owner-occupied fix-and-flip transactions in California. Investors can submit an existing term sheet to Silverback Capital for a confidential, like-for-like review covering interest rate, lender points, fees, initial loan proceeds, rehabilitation holdback, leverage and total estimated financing cost.

Valencia, Calif. – September 21, 2026 -- Bioness Medical, Inc. has commercially launched HaloPlex, an FDA-registered ceiling-mounted body weight support and fall protection system aimed at rehabilitation hospitals, outpatient clinics, and rehab centers treating patients with severe gait and balance impairments.

HaloPlex extends the Vector Gait & Safety System with multidirectional movement support

The system unloads a programmed amount of a patient's body weight while providing continuous postural support and overhead fall protection, allowing patients to practice walking, balance activities, transfers, and functional mobility tasks across a larger therapy space.

New York – September 21, 2026 -- Hartree Partners has agreed to purchase and market approximately 10,000 metric tons per year of lithium carbonate from Bridge Green Upcycle under an eight-year commercial agreement valued at an estimated $500 million to $1 billion at current market conditions.

Hartree secures exclusive marketing rights across all lithium carbonate grades produced at Bridge Green facilities

The agreement grants Hartree exclusive marketing rights for lithium carbonate produced by Bridge Green during the initial term, with an option to renew for an additional seven years. Hartree also made an equity investment in Bridge Green's bridge financing round, funding the company's planned expansion of battery recycling and critical-mineral refining. First lithium carbonate volumes under the agreement are projected for 2028.

Jiangmen, China – September 21, 2026 -- Jiangmen Meixin Comb Brush Machinery Co., Ltd. is marking its 38th year of operation, having built a client base spanning Germany, the UK, Turkey, Brazil, Peru and Kenya, alongside broader market share across Asia, the Middle East and South America.

Founded in 1988, the company has grown into one of China's established brush-making machinery manufacturers, holding multiple invention, utility and design patents. One-third of its engineering staff carries more than two decades of factory-floor experience, feeding directly into equipment design.

Gainesville, Fla. – September 21, 2026 -- Advita Ortho has launched Axis, a clinical research platform drawing on more than 20 years of shoulder arthroplasty data covering over 25,000 patients across 45 clinical sites worldwide.

Two decades of data produce 250 peer-reviewed studies

The dataset behind Axis has generated more than 250 peer-reviewed publications and dozens of first-to-market product innovations, according to the company. Chris Roche, Advita Senior Vice President, Extremities, said the initiative distills findings from the company's highest-impact studies into a format designed for practicing surgeons.

New York – September 21, 2026 -- FADEL and Gournay Consulting have launched a new connector integrating Bynder's digital asset management platform with FADEL Brand Vision, adding rights intelligence and AI-powered content tracking to brand compliance workflows.

Connector links Bynder's asset library to FADEL's rights and compliance engine

Built by Gournay Consulting, a premier Bynder partner, the integration keeps Bynder as the system of record for managing and distributing digital assets while FADEL Brand Vision supplies usage rights, restrictions, and expiration data tied to each asset. Users can validate rights clearance for a specific timeframe, format, and territory without leaving the Bynder interface.

New York – September 21, 2026 -- The Appeal of Conscience Foundation will honor Raj Subramaniam, President and CEO of FedEx Corporation, with its Appeal of Conscience Award at the 61st Annual Gala on September 23, 2026, at The Pierre Hotel in New York City.

Foundation cites Subramaniam's leadership in global trade connectivity

Rabbi Arthur Schneier, Founder and President of the Appeal of Conscience Foundation, said Subramaniam is being recognized for his international visionary leadership and commitment to connecting people worldwide through innovation and service. Schneier noted that under Subramaniam's stewardship, FedEx has advanced a culture of social and global responsibility.

New York – September 21, 2026 -- Guideline, a global provider of advertising intelligence and media plan management technology, has introduced Guideline Signal, a platform delivering ticker-level advertising data, KPI forecasts and market intelligence to investment professionals ahead of quarterly earnings. The platform becomes generally available on October 1, 2026.

Signal draws on a dataset already used by more than 50 of the world's largest hedge funds

The underlying dataset reflects roughly $200 billion in annual transactional advertising spend, sourced directly from every major holding group and numerous large independent media agencies. Because the data is captured at multiple points before a company reports quarterly results, investors can track shifts in advertising demand for a given ticker before earnings are announced.

Munich – September 21, 2026 -- Manifold Tech Limited has partnered with FARO INSIGHT, a business of AMETEK, Inc., to launch Rovi i.1, a mobile reality capture device that feeds directly into FARO's Sphere XG Digital Reality Platform.

Rovi i.1 combines real-time localization with 3D Gaussian Splatting for field data capture

The device merges real-time localization, geometry, imagery and 3D Gaussian Splatting (3DGS) technology to generate spatial datasets and photorealistic 3D environments from a single field workflow. It is designed as a mobile, everyday-use tool rather than a standalone capture instrument.